Lista de obras - Julie Lucifora - Dominio Público Uruguay

5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice

artículo científico publicado en 2011

Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure

artículo científico publicado en 2016

Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines

artículo científico publicado en 2018

Control of hepatitis B virus replication by innate response of HepaRG cells.

artículo científico publicado en 2010

Current knowledge on Hepatitis Delta Virus replication

scientific article published on 29 April 2020

Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

artículo científico publicado en 2017

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.

artículo científico publicado en 2018

Dégradation spécifique de l’ADN nucléaire responsable de la persistance du virus de l’hépatite B

article

Early inhibition of hepatocyte innate responses by hepatitis B virus.

artículo científico publicado en 2015

Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.

artículo científico publicado en 2015

Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.

artículo científico publicado en 2012

Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus Infections

artículo científico publicado en 2020

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes

artículo científico publicado en 2016

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

artículo científico publicado en 2020

Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

artículo científico publicado en 2011

Hepatitis B virus evasion from cGAS sensing in human hepatocytes.

artículo científico publicado en 2018

Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

artículo científico publicado en 2011

Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo.

artículo científico publicado en 2014

Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model.

artículo científico publicado en 2010

Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection

artículo científico publicado en 2019

Hepatitis: After HCV cure, HBV cure?

artículo científico publicado en 2015

Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies

artículo científico

Innate antiviral immune responses to hepatitis B virus.

artículo científico

Interaction between TLR9-CpG-ODNs and HBV virions leads to entry inhibition in hepatocytes and reduction of IFNα production by pDC.

artículo científico publicado en 2018

Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

artículo científico publicado en 2015

Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

artículo científico publicado en 2017

Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle.

artículo científico publicado en 2018

Liver macrophages: Friend or foe during hepatitis B infection?

artículo científico publicado en 2018

New pharmacological strategies to fight enveloped viruses

artículo científico publicado en 2014

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

artículo científico publicado en 2014

Toll-Like Receptor 7 Agonist GS-9620 Induces Prolonged Inhibition of HBV via a Type I Interferon-Dependent Mechanism

artículo científico publicado en 2017

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

artículo científico publicado en 2015

Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work!

artículo científico publicado en 2020

Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

artículo científico publicado en 2014

[The ISG20 protein, a new restriction factor against hepatitis B virus?]

artículo científico publicado en 2018

[gMDSCs act as metabolic regulators of hepatitis B virus immunopathology].

artículo científico publicado en 2016

Lista de obras de Julie Lucifora

5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice

Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure

Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines

Control of hepatitis B virus replication by innate response of HepaRG cells.

Current knowledge on Hepatitis Delta Virus replication

Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.

Dégradation spécifique de l’ADN nucléaire responsable de la persistance du virus de l’hépatite B

Early inhibition of hepatocyte innate responses by hepatitis B virus.

Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.

Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.

Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus Infections

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

Hepatitis B virus evasion from cGAS sensing in human hepatocytes.

Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo.

Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model.

Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection

Hepatitis: After HCV cure, HBV cure?

Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies

Innate antiviral immune responses to hepatitis B virus.

Interaction between TLR9-CpG-ODNs and HBV virions leads to entry inhibition in hepatocytes and reduction of IFNα production by pDC.

Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle.

Liver macrophages: Friend or foe during hepatitis B infection?

New pharmacological strategies to fight enveloped viruses

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

Toll-Like Receptor 7 Agonist GS-9620 Induces Prolonged Inhibition of HBV via a Type I Interferon-Dependent Mechanism

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work!

Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

[The ISG20 protein, a new restriction factor against hepatitis B virus?]

[gMDSCs act as metabolic regulators of hepatitis B virus immunopathology].